The Invisible Alchemists

How Japanese Neurochemists Decoded the Brain's Language Over 50 Years

The Silent Revolution

Beneath the surface of our thoughts, memories, and emotions lies an intricate world of molecular conversations. For 50 years, The Japanese Society for Neurochemistry (JSN) has served as the premier interpreter of this biochemical language, transforming our understanding of the brain's inner workings.

From pioneering studies on lipid signaling to cutting-edge explorations of "digital brains," Japanese researchers have consistently bridged molecular mechanisms and neurological function. This golden anniversary coincides with a pivotal moment: the integration of artificial intelligence with neurochemistry, revolutionary imaging of neurotransmitter dynamics, and international collaborations tackling neurodegeneration.

As we celebrate JSN's legacy, we stand at the threshold of decoding the brain's most profound secrets 5 8 .

The Alchemy of Thought – Foundations and Milestones

Historical Convergence

The JSN's founding (1975) emerged from a scientific awakening: the realization that neurotransmitters like serotonin and glutamate were not mere chemicals but the alphabet of cognition.

Metabolic Crossroads

Discovery of the lactate shuttle (astrocyte-to-neuron energy transfer), revealing how glial cells fuel neuronal activity.

Lipid Messengers

Characterization of brain-specific lipids regulating synaptic plasticity, linking membrane dynamics to learning.

Disease Pathways

Elucidating β-amyloid toxicity cascades, positioning Japanese researchers at the forefront of Alzheimer's research 9 .

The Glial Revolution

Once considered "neural glue," glial cells are now recognized as master regulators of brain function.

Synchronize neuronal ensembles

Mechanisms protecting synapses

In multiple sclerosis

Prof. Flávia Gomes' recent special issue in Neurochemical Research highlights Japan-Brazil collaborations exploring glia-neuron metabolic coupling—a testament to JSN's global influence 2 .

Tools of Revelation

Technology Japanese Pioneer Impact
Patch-clamp recording Susumu Numa (Kyoto) First measurements of single-ion channels
FRET biosensors Takeharu Nagai (Osaka) Real-time imaging of cAMP in live cells
AAV gene delivery Ayumu Konno (Gunma) Targeted neural circuit manipulation

These tools laid groundwork for today's molecular neuroscience 4 .

Decoding Neuroinflammation – A Landmark Experiment

The METTL3 Breakthrough: How m6A Methylation Controls Microglia

Neuroinflammation is the dark undercurrent of Alzheimer's, Parkinson's, and ALS. A 2025 study exemplifies JSN's innovative approach to molecular mechanisms 9 .

Methodology: The RNA Editing Hypothesis

Researchers hypothesized that N6-methyladenosine (m6A), an RNA modification, regulates microglial polarization (M1 pro-inflammatory vs. M2 anti-inflammatory states):

Model Systems
  • In vitro: Human microglia treated with Aβ1-42 oligomers
  • In vivo: APPswe/PS1dE9 transgenic mice
Genetic Manipulation
  • CRISPR/Cas9 knockout of METTL3 and IGF2BP2
  • Overexpression of IκBα via lentiviral vectors
Assays
  • RNA immunoprecipitation (RIP)
  • Multiplex cytokine profiling
  • Morris water maze tests
Results: The m6A-IκBα Axis
Group Escape Latency (s) IL-1β (pg/mL) M1/M2 Marker Ratio
Wild-type mice 18.2 ± 2.1 12.3 ± 1.8 0.31 ± 0.05
Untreated Alzheimer's 48.7 ± 5.6 89.4 ± 10.2 3.27 ± 0.41
METTL3-overexpression 25.3 ± 3.9* 29.8 ± 4.7* 0.98 ± 0.12*

*Data represent mean ± SEM; *p<0.01 vs. Untreated Alzheimer's 9

Key Findings
  • Aβ1-42 reduced m6A on IκBα mRNA by 62%
  • This unleashed NF-κB-driven inflammation
  • Restoring METTL3/IGF2BP2 prolonged IκBα half-life 3.2-fold
Implications
  • m6A as a critical "brake" on neuroinflammation
  • Potential for RNA epitranscriptomic drugs
  • How metabolic crosstalk modulates microglial epigenetics

The Neurochemist's Toolkit

AAV-PHP.eB vectors

Cross-blood-brain-barrier gene delivery

Overexpression of METTL3 in microglia 4

m6A-seq kits

Genome-wide mapping of RNA modifications

Identifying neuroinflammatory "hotspots"

Memristive nanomaterials

Neuromorphic computation mimicking synapses

AI-driven drug screening 7

SCIENTA biosensors

Real-time dopamine/glutamate monitoring

Decoding reward circuitry

CRISPR-SAM activation

Targeted gene upregulation without DNA break

IκBα enhancement in Alzheimer's models

Emerging Game-Changers

Hydrogel scaffolds

For 3D neurodegenerative disease modeling

Carbon nanotube electrodes

Tracking single-neuron ion fluxes

Selenium-tellurium oxide transistors

Enabling low-power brain interfaces 7

The Next 50 Years – Three Visions

The "Brain Observatory" Initiative

Goal: Map molecular dynamics across 1 billion synapses in real-time

Tools: Quantum sensors + memristive nanoarrays (processing speed: 10^15 ops/sec) 7

Precision Molecular Psychiatry

Approach: CRISPR-based RNA editors correcting m6A in patient-derived neurons

Targets: Depression (5-HT4 receptors), addiction (mu-opioid circuits) 9

Carbon-Neutral Neurotech

Development: Perovskite solar-powered brain implants for neuromodulation

Benefit: 80% lower energy use than conventional devices 7

Conclusion: The Unfinished Symphony

The JSN's 50-year journey mirrors the brain's own complexity—layer upon layer of discovery revealing ever-deeper questions. As we celebrate past achievements, from lipid signaling to digital brain models, we recognize that neurochemistry is no longer confined to test tubes. It is the bridge connecting quantum physics to consciousness, ethics to artificial intelligence, and molecules to the human experience.

The society's anniversary theme—"Creating a 'Brain Observatory' for Unraveling the Brain Universe"—aptly captures our aspirational future: not just to observe, but to comprehend, heal, and ultimately harmonize the biochemical symphony within us all 5 8 .

"The greatest alchemy begins not with lead, but with curiosity."

Adapted from Yuji Ikegaya (2025 JSN Special Lecturer) 4

References